

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.98346201 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.98346201 |
| 3 | complement activation, alternative pathway (GO:0006957) | 6.97790900 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.67039308 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.67039308 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.20674156 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.15043698 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.08292867 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 5.97878844 |
| 10 | exogenous drug catabolic process (GO:0042738) | 5.94983249 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.73142174 |
| 12 | * regulation of protein activation cascade (GO:2000257) | 5.72975357 |
| 13 | glucocorticoid biosynthetic process (GO:0006704) | 5.53602139 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.53518198 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.53518198 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.53518198 |
| 17 | protein carboxylation (GO:0018214) | 5.52229626 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.52229626 |
| 19 | bile acid biosynthetic process (GO:0006699) | 5.47966970 |
| 20 | kynurenine metabolic process (GO:0070189) | 5.44319223 |
| 21 | * regulation of complement activation (GO:0030449) | 5.41606430 |
| 22 | urea metabolic process (GO:0019627) | 5.39760888 |
| 23 | urea cycle (GO:0000050) | 5.39760888 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.26154190 |
| 25 | glyoxylate metabolic process (GO:0046487) | 5.23828910 |
| 26 | tryptophan metabolic process (GO:0006568) | 5.19791207 |
| 27 | * regulation of apoptotic cell clearance (GO:2000425) | 5.11153943 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.07861967 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05044038 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.96153441 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95013120 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.94863486 |
| 33 | cysteine metabolic process (GO:0006534) | 4.81127594 |
| 34 | regulation of plasminogen activation (GO:0010755) | 4.75310358 |
| 35 | bile acid metabolic process (GO:0008206) | 4.71464292 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.67651636 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.64548581 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.57758205 |
| 39 | serine family amino acid catabolic process (GO:0009071) | 4.57687543 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.52980318 |
| 41 | phospholipid efflux (GO:0033700) | 4.48166299 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.46572023 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.46572023 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 4.46258860 |
| 45 | macromolecular complex remodeling (GO:0034367) | 4.46258860 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 4.46258860 |
| 47 | * complement activation (GO:0006956) | 4.42945418 |
| 48 | aromatic amino acid family metabolic process (GO:0009072) | 4.42149046 |
| 49 | tyrosine metabolic process (GO:0006570) | 4.39763839 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.39638811 |
| 51 | ethanol metabolic process (GO:0006067) | 4.29826975 |
| 52 | glucocorticoid metabolic process (GO:0008211) | 4.26050382 |
| 53 | alpha-amino acid catabolic process (GO:1901606) | 4.25337124 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.23868627 |
| 55 | drug metabolic process (GO:0017144) | 4.21264023 |
| 56 | lysine metabolic process (GO:0006553) | 4.19876795 |
| 57 | lysine catabolic process (GO:0006554) | 4.19876795 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.17792147 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.17792147 |
| 60 | negative regulation of complement activation (GO:0045916) | 4.13976828 |
| 61 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.12339908 |
| 62 | * protein activation cascade (GO:0072376) | 4.12028222 |
| 63 | negative regulation of hemostasis (GO:1900047) | 4.08502559 |
| 64 | negative regulation of blood coagulation (GO:0030195) | 4.08502559 |
| 65 | * complement activation, classical pathway (GO:0006958) | 4.08128193 |
| 66 | ethanol oxidation (GO:0006069) | 4.06338055 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.04780118 |
| 68 | cholesterol efflux (GO:0033344) | 4.04696445 |
| 69 | coenzyme catabolic process (GO:0009109) | 4.04640475 |
| 70 | bile acid and bile salt transport (GO:0015721) | 3.99871023 |
| 71 | glutamate metabolic process (GO:0006536) | 3.95754337 |
| 72 | fibrinolysis (GO:0042730) | 3.92744447 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.91227077 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.88265005 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.88225581 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.86939091 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 3.86329283 |
| 78 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.84702954 |
| 79 | glycine metabolic process (GO:0006544) | 3.79599969 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.79580819 |
| 81 | uronic acid metabolic process (GO:0006063) | 3.79580819 |
| 82 | cellular modified amino acid catabolic process (GO:0042219) | 3.79552491 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.76427174 |
| 84 | amine catabolic process (GO:0009310) | 3.74053075 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 3.74053075 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.74009965 |
| 87 | androgen biosynthetic process (GO:0006702) | 3.72306635 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.72206303 |
| 89 | intestinal cholesterol absorption (GO:0030299) | 3.71273942 |
| 90 | oxidative demethylation (GO:0070989) | 3.71029227 |
| 91 | negative regulation of coagulation (GO:0050819) | 3.70403883 |
| 92 | cellular glucuronidation (GO:0052695) | 3.69982591 |
| 93 | negative regulation of wound healing (GO:0061045) | 3.68047704 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.67366779 |
| 95 | benzene-containing compound metabolic process (GO:0042537) | 3.65958090 |
| 96 | acetyl-CoA metabolic process (GO:0006084) | 3.65225536 |
| 97 | protein-lipid complex subunit organization (GO:0071825) | 3.63031008 |
| 98 | acute-phase response (GO:0006953) | 3.62206352 |
| 99 | serine family amino acid metabolic process (GO:0009069) | 3.61580929 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 3.61027073 |
| 101 | positive regulation of hemostasis (GO:1900048) | 3.61027073 |
| 102 | arginine metabolic process (GO:0006525) | 3.60928964 |
| 103 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.60173774 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.59873914 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.59873914 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.58761609 |
| 107 | cytolysis (GO:0019835) | 3.56851761 |
| 108 | acute inflammatory response (GO:0002526) | 3.56828442 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.56528896 |
| 110 | protein-lipid complex assembly (GO:0065005) | 3.54440550 |
| 111 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.54218916 |
| 112 | sterol homeostasis (GO:0055092) | 3.52817397 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.51773890 |
| 114 | * opsonization (GO:0008228) | 3.51159662 |
| 115 | plasma lipoprotein particle organization (GO:0071827) | 3.50175197 |
| 116 | aldehyde catabolic process (GO:0046185) | 3.49048752 |
| 117 | negative regulation of protein activation cascade (GO:2000258) | 3.48398936 |
| 118 | organic acid catabolic process (GO:0016054) | 3.48277076 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.48277076 |
| 120 | * regulation of acute inflammatory response (GO:0002673) | 3.47380087 |
| 121 | drug catabolic process (GO:0042737) | 3.46088257 |
| 122 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.44908930 |
| 123 | * regulation of humoral immune response (GO:0002920) | 3.44612452 |
| 124 | cofactor catabolic process (GO:0051187) | 3.43525800 |
| 125 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41914773 |
| 126 | lipoprotein metabolic process (GO:0042157) | 3.40325225 |
| 127 | positive regulation of steroid metabolic process (GO:0045940) | 3.38597779 |
| 128 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.36760206 |
| 129 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.36760206 |
| 130 | short-chain fatty acid metabolic process (GO:0046459) | 3.36015851 |
| 131 | serine family amino acid biosynthetic process (GO:0009070) | 3.35412149 |
| 132 | positive regulation of coagulation (GO:0050820) | 3.31831988 |
| 133 | phenylpropanoid metabolic process (GO:0009698) | 3.30262272 |
| 134 | negative regulation of humoral immune response (GO:0002921) | 3.29030929 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 3.26415800 |
| 136 | response to mercury ion (GO:0046689) | 3.25062064 |
| 137 | sterol transport (GO:0015918) | 3.10812198 |
| 138 | cholesterol transport (GO:0030301) | 3.10812198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.74139658 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.67434165 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.09760693 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.03280730 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.56819705 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95626368 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.41852653 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93095168 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.46029588 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.24432554 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09456185 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.9881203 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.98871361 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88573065 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.76041332 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63388392 |
| 17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.60860233 |
| 18 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.60388847 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51520038 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41144241 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37024775 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31043569 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30042650 |
| 24 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28964805 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.24862685 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19328201 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19048343 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.12946186 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11534705 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.08799860 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06900403 |
| 32 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06601732 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06042710 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05167815 |
| 35 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04255679 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02213985 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99039538 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94322861 |
| 39 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93875233 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92742318 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92722098 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92452834 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91527619 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90226535 |
| 45 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.87305701 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85777211 |
| 47 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84723743 |
| 48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84206476 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83386002 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81617447 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78017218 |
| 52 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.77104852 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74238899 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 0.73777183 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.72731984 |
| 56 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72134518 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72089867 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71979572 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71485803 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71485803 |
| 61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.70412298 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.68868968 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.68868351 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67839022 |
| 65 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.67432233 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67169083 |
| 67 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.66947498 |
| 68 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66912531 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.66776960 |
| 70 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.66716099 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66547609 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65454331 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.65346953 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.65309027 |
| 75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65032928 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.64327079 |
| 77 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.64323030 |
| 78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64026112 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63797090 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63141653 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.62935502 |
| 82 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62935427 |
| 83 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61985478 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.61926432 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61531760 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.61506933 |
| 87 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.61436332 |
| 88 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.61125236 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.61072770 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.61052849 |
| 91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60323127 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.60097133 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59991399 |
| 94 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.59294297 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58429574 |
| 96 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58177571 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57761005 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.57681728 |
| 99 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56565174 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55106559 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.54692520 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.53931240 |
| 103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53568886 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53540790 |
| 105 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.53491651 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.53299300 |
| 107 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52180545 |
| 108 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.51830102 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51265713 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51123750 |
| 111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50743748 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48545191 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47822409 |
| 114 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.47819606 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47428613 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.47342293 |
| 117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46936445 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45848221 |
| 119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45338736 |
| 120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.45240679 |
| 121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.45216355 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.45216355 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.45159379 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.44792247 |
| 125 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43683362 |
| 126 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43602971 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42983501 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42952822 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42881866 |
| 130 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.42532805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.54864599 |
| 2 | MP0005360_urolithiasis | 6.91597401 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.86311128 |
| 4 | MP0005365_abnormal_bile_salt | 5.77514249 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.64188421 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.77140604 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.67686510 |
| 8 | MP0003252_abnormal_bile_duct | 3.60989791 |
| 9 | MP0009840_abnormal_foam_cell | 3.57789834 |
| 10 | MP0005083_abnormal_biliary_tract | 2.86684579 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.85418789 |
| 12 | MP0005332_abnormal_amino_acid | 2.65963099 |
| 13 | MP0003195_calcinosis | 2.56846956 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.38611321 |
| 15 | MP0002118_abnormal_lipid_homeostasis | 2.23792432 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.19104953 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.02871416 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.87211093 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 1.81527240 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81003548 |
| 21 | MP0002909_abnormal_adrenal_gland | 1.75709022 |
| 22 | MP0005670_abnormal_white_adipose | 1.73151554 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58319985 |
| 24 | MP0003868_abnormal_feces_composition | 1.56834043 |
| 25 | MP0001764_abnormal_homeostasis | 1.52686770 |
| 26 | MP0000604_amyloidosis | 1.39462726 |
| 27 | MP0002254_reproductive_system_inflammat | 1.36588211 |
| 28 | MP0003879_abnormal_hair_cell | 1.36052982 |
| 29 | MP0003011_delayed_dark_adaptation | 1.35003981 |
| 30 | MP0010368_abnormal_lymphatic_system | 1.25209344 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.25046937 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.23757022 |
| 33 | MP0004130_abnormal_muscle_cell | 1.22401722 |
| 34 | MP0000598_abnormal_liver_morphology | 1.20737976 |
| 35 | MP0003724_increased_susceptibility_to | 1.19773101 |
| 36 | MP0008004_abnormal_stomach_pH | 1.18875746 |
| 37 | MP0003690_abnormal_glial_cell | 1.17393286 |
| 38 | MP0001915_intracranial_hemorrhage | 1.16789376 |
| 39 | MP0003186_abnormal_redox_activity | 1.16013813 |
| 40 | MP0005451_abnormal_body_composition | 1.12424119 |
| 41 | * MP0009763_increased_sensitivity_to | 1.11567312 |
| 42 | MP0002971_abnormal_brown_adipose | 1.09118367 |
| 43 | MP0009697_abnormal_copulation | 1.07433965 |
| 44 | MP0000678_abnormal_parathyroid_gland | 1.07069130 |
| 45 | MP0005647_abnormal_sex_gland | 1.03906086 |
| 46 | MP0009764_decreased_sensitivity_to | 1.03773977 |
| 47 | MP0000566_synostosis | 1.01797316 |
| 48 | MP0008469_abnormal_protein_level | 0.98864865 |
| 49 | MP0003436_decreased_susceptibility_to | 0.98449248 |
| 50 | MP0005058_abnormal_lysosome_morphology | 0.95723881 |
| 51 | MP0005666_abnormal_adipose_tissue | 0.94705827 |
| 52 | MP0003075_altered_response_to | 0.94331160 |
| 53 | MP0002132_abnormal_respiratory_system | 0.93467037 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 0.93183262 |
| 55 | MP0005334_abnormal_fat_pad | 0.92333584 |
| 56 | MP0009642_abnormal_blood_homeostasis | 0.89756249 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 0.88952579 |
| 58 | MP0002249_abnormal_larynx_morphology | 0.87364291 |
| 59 | MP0003329_amyloid_beta_deposits | 0.86091996 |
| 60 | MP0005535_abnormal_body_temperature | 0.85787759 |
| 61 | MP0004272_abnormal_basement_membrane | 0.85544423 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 0.82107261 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.80698677 |
| 64 | MP0005464_abnormal_platelet_physiology | 0.80347204 |
| 65 | MP0000920_abnormal_myelination | 0.79300755 |
| 66 | MP0005409_darkened_coat_color | 0.78541108 |
| 67 | MP0005636_abnormal_mineral_homeostasis | 0.78175987 |
| 68 | MP0001661_extended_life_span | 0.72923866 |
| 69 | MP0005448_abnormal_energy_balance | 0.71548518 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.71257011 |
| 71 | MP0003566_abnormal_cell_adhesion | 0.70693709 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.70162293 |
| 73 | MP0003878_abnormal_ear_physiology | 0.70162293 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.69451255 |
| 75 | MP0001756_abnormal_urination | 0.68478375 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.68462293 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 0.64341884 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.64135372 |
| 79 | MP0005408_hypopigmentation | 0.63993810 |
| 80 | MP0005595_abnormal_vascular_smooth | 0.63742622 |
| 81 | MP0001984_abnormal_olfaction | 0.60338172 |
| 82 | MP0005166_decreased_susceptibility_to | 0.60231606 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.60086695 |
| 84 | MP0009115_abnormal_fat_cell | 0.59999351 |
| 85 | MP0002282_abnormal_trachea_morphology | 0.59882675 |
| 86 | MP0009053_abnormal_anal_canal | 0.59665251 |
| 87 | MP0002933_joint_inflammation | 0.58520983 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.58304149 |
| 89 | MP0002168_other_aberrant_phenotype | 0.57619661 |
| 90 | MP0001533_abnormal_skeleton_physiology | 0.55220845 |
| 91 | MP0003632_abnormal_nervous_system | 0.54845616 |
| 92 | MP0002089_abnormal_postnatal_growth/wei | 0.54397205 |
| 93 | MP0002896_abnormal_bone_mineralization | 0.53394545 |
| 94 | * MP0002136_abnormal_kidney_physiology | 0.52917757 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.52335110 |
| 96 | MP0002837_dystrophic_cardiac_calcinosis | 0.52188812 |
| 97 | * MP0000249_abnormal_blood_vessel | 0.51944877 |
| 98 | MP0005395_other_phenotype | 0.51065415 |
| 99 | MP0004782_abnormal_surfactant_physiolog | 0.50591409 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.50080855 |
| 101 | MP0004947_skin_inflammation | 0.49323892 |
| 102 | MP0002060_abnormal_skin_morphology | 0.48684525 |
| 103 | MP0008874_decreased_physiological_sensi | 0.48642364 |
| 104 | MP0002970_abnormal_white_adipose | 0.48544481 |
| 105 | MP0004858_abnormal_nervous_system | 0.47770128 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.47629603 |
| 107 | MP0002796_impaired_skin_barrier | 0.47433043 |
| 108 | MP0005023_abnormal_wound_healing | 0.47392299 |
| 109 | MP0003633_abnormal_nervous_system | 0.46851444 |
| 110 | MP0005266_abnormal_metabolism | 0.45674341 |
| 111 | MP0008873_increased_physiological_sensi | 0.45016675 |
| 112 | MP0003279_aneurysm | 0.44848491 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.44210686 |
| 114 | MP0002419_abnormal_innate_immunity | 0.44162657 |
| 115 | MP0001881_abnormal_mammary_gland | 0.44111779 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.42974990 |
| 117 | MP0002928_abnormal_bile_duct | 0.42903948 |
| 118 | MP0001853_heart_inflammation | 0.42022866 |
| 119 | * MP0001845_abnormal_inflammatory_respons | 0.41483883 |
| 120 | MP0003953_abnormal_hormone_level | 0.40883807 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.40767219 |
| 122 | MP0005164_abnormal_response_to | 0.40726914 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.40060464 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.40036489 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.38777736 |
| 126 | MP0009384_cardiac_valve_regurgitation | 0.38549114 |
| 127 | MP0004883_abnormal_blood_vessel | 0.38152093 |
| 128 | MP0006082_CNS_inflammation | 0.37770593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.44906256 |
| 2 | Complement deficiency (HP:0004431) | 7.05290263 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.54506598 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.51946428 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.47262843 |
| 6 | Xanthomatosis (HP:0000991) | 6.07657533 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.98302251 |
| 8 | Abnormality of complement system (HP:0005339) | 5.57182915 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.52825142 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.45327374 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 5.17700855 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.78506449 |
| 13 | Joint hemorrhage (HP:0005261) | 4.74127661 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.39432124 |
| 15 | Epidermoid cyst (HP:0200040) | 4.35128426 |
| 16 | Hyperammonemia (HP:0001987) | 4.18913146 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.11381860 |
| 18 | Glomerulonephritis (HP:0000099) | 4.07115497 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.06869041 |
| 20 | Hyperglycinemia (HP:0002154) | 3.99742724 |
| 21 | Ketosis (HP:0001946) | 3.89491056 |
| 22 | Hyperglycinuria (HP:0003108) | 3.75695187 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.75531370 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70966188 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66497295 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.66497295 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.60526962 |
| 28 | Fat malabsorption (HP:0002630) | 3.60140808 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.58245463 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.57109596 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51305920 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.48970122 |
| 33 | Myocardial infarction (HP:0001658) | 3.29794057 |
| 34 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21601097 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.18038296 |
| 36 | Purpura (HP:0000979) | 3.13880055 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13246735 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.12648509 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.08045577 |
| 40 | Spontaneous abortion (HP:0005268) | 3.07049978 |
| 41 | Hyperbilirubinemia (HP:0002904) | 2.87924764 |
| 42 | Skin nodule (HP:0200036) | 2.79500368 |
| 43 | Ketoacidosis (HP:0001993) | 2.79126839 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.76108070 |
| 45 | Nephritis (HP:0000123) | 2.75715876 |
| 46 | Mitral stenosis (HP:0001718) | 2.75256878 |
| 47 | Amyloidosis (HP:0011034) | 2.73571270 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.70992377 |
| 49 | Hepatocellular carcinoma (HP:0001402) | 2.65627404 |
| 50 | Steatorrhea (HP:0002570) | 2.64910525 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.57837851 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.57286644 |
| 53 | Esophageal varix (HP:0002040) | 2.51814121 |
| 54 | Menorrhagia (HP:0000132) | 2.51630706 |
| 55 | Vascular calcification (HP:0004934) | 2.44768008 |
| 56 | Gingival bleeding (HP:0000225) | 2.41639544 |
| 57 | Hypochromic microcytic anemia (HP:0004840) | 2.39970945 |
| 58 | Hemorrhage of the eye (HP:0011885) | 2.35787419 |
| 59 | Metabolic acidosis (HP:0001942) | 2.31366979 |
| 60 | Hypoglycemic seizures (HP:0002173) | 2.28369309 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.27457521 |
| 62 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27457521 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.26850157 |
| 64 | Spastic diplegia (HP:0001264) | 2.25046198 |
| 65 | Cholelithiasis (HP:0001081) | 2.24082013 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.22408615 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.20965030 |
| 68 | Cholecystitis (HP:0001082) | 2.20965030 |
| 69 | Acanthocytosis (HP:0001927) | 2.17150591 |
| 70 | Decreased circulating renin level (HP:0003351) | 2.15812256 |
| 71 | Rickets (HP:0002748) | 2.15407524 |
| 72 | Lethargy (HP:0001254) | 2.13285073 |
| 73 | Irritability (HP:0000737) | 2.12665574 |
| 74 | Gout (HP:0001997) | 2.11836708 |
| 75 | Thrombophlebitis (HP:0004418) | 2.11643706 |
| 76 | Neonatal onset (HP:0003623) | 2.08266611 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.08141358 |
| 78 | Late onset (HP:0003584) | 2.06771139 |
| 79 | Facial shape deformation (HP:0011334) | 2.01787237 |
| 80 | Potter facies (HP:0002009) | 2.01787237 |
| 81 | Malnutrition (HP:0004395) | 2.01702066 |
| 82 | Hypertriglyceridemia (HP:0002155) | 1.99197171 |
| 83 | Pancreatitis (HP:0001733) | 1.96633572 |
| 84 | Orchitis (HP:0100796) | 1.96532016 |
| 85 | Hydroxyprolinuria (HP:0003080) | 1.88748857 |
| 86 | Abnormality of proline metabolism (HP:0010907) | 1.88748857 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 1.87129422 |
| 88 | Optic neuritis (HP:0100653) | 1.87129422 |
| 89 | Joint swelling (HP:0001386) | 1.86880882 |
| 90 | Peritonitis (HP:0002586) | 1.86039944 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 1.84742925 |
| 92 | Brushfield spots (HP:0001088) | 1.84030715 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 1.83420297 |
| 94 | Vomiting (HP:0002013) | 1.83044607 |
| 95 | Turricephaly (HP:0000262) | 1.82722205 |
| 96 | Neurofibrillary tangles (HP:0002185) | 1.82250530 |
| 97 | Osteomalacia (HP:0002749) | 1.81753004 |
| 98 | Acute hepatic failure (HP:0006554) | 1.80941855 |
| 99 | Abnormal cartilage morphology (HP:0002763) | 1.79851839 |
| 100 | Cerebral edema (HP:0002181) | 1.79767088 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.78939729 |
| 102 | Opisthotonus (HP:0002179) | 1.78365973 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78157075 |
| 104 | Renal salt wasting (HP:0000127) | 1.77791351 |
| 105 | Enlarged kidneys (HP:0000105) | 1.76664832 |
| 106 | Pulmonary embolism (HP:0002204) | 1.72912167 |
| 107 | Lymphangioma (HP:0100764) | 1.71240821 |
| 108 | Hyperglycemia (HP:0003074) | 1.70003654 |
| 109 | Elevated hepatic transaminases (HP:0002910) | 1.68576025 |
| 110 | Enlarged penis (HP:0000040) | 1.68020049 |
| 111 | Atrioventricular block (HP:0001678) | 1.66271469 |
| 112 | Generalized aminoaciduria (HP:0002909) | 1.66266118 |
| 113 | Stroke (HP:0001297) | 1.66184658 |
| 114 | Gangrene (HP:0100758) | 1.65913487 |
| 115 | Abnormal delivery (HP:0001787) | 1.65697334 |
| 116 | Epistaxis (HP:0000421) | 1.64142125 |
| 117 | Poikilocytosis (HP:0004447) | 1.63456875 |
| 118 | Arthropathy (HP:0003040) | 1.63070155 |
| 119 | Hyperaldosteronism (HP:0000859) | 1.58656747 |
| 120 | Bifid scrotum (HP:0000048) | 1.57573057 |
| 121 | Elevated alkaline phosphatase (HP:0003155) | 1.55470936 |
| 122 | Mesangial abnormality (HP:0001966) | 1.53148387 |
| 123 | Visceral angiomatosis (HP:0100761) | 1.51275086 |
| 124 | Abnormality of carpal bone ossification (HP:0006257) | 1.50875606 |
| 125 | Protrusio acetabuli (HP:0003179) | 1.48654375 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.48055687 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.48055687 |
| 128 | Cerebral palsy (HP:0100021) | 1.46494115 |
| 129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.45306523 |
| 130 | Increased serum ferritin (HP:0003281) | 1.45255001 |
| 131 | J-shaped sella turcica (HP:0002680) | 1.45162398 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.44979479 |
| 133 | Alkalosis (HP:0001948) | 1.44796908 |
| 134 | Myositis (HP:0100614) | 1.43717620 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.43711507 |
| 136 | Hypophosphatemia (HP:0002148) | 1.41568506 |
| 137 | Abnormal tarsal ossification (HP:0008369) | 1.40647059 |
| 138 | Hemangiomatosis (HP:0007461) | 1.39714245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.96640577 |
| 2 | ERN1 | 4.82160391 |
| 3 | MST1R | 4.40991869 |
| 4 | SIK1 | 4.17235445 |
| 5 | FGFR4 | 3.87361824 |
| 6 | AKT3 | 3.41163351 |
| 7 | TRIB3 | 3.01070520 |
| 8 | TAOK3 | 2.88244282 |
| 9 | CAMK1D | 2.59278633 |
| 10 | INSRR | 2.43756120 |
| 11 | DAPK2 | 2.22837853 |
| 12 | PKN2 | 2.11896796 |
| 13 | ERBB4 | 2.07202005 |
| 14 | DDR2 | 1.94165296 |
| 15 | TYK2 | 1.86457682 |
| 16 | RIPK1 | 1.85184074 |
| 17 | CAMK1G | 1.83889388 |
| 18 | MET | 1.80392352 |
| 19 | MAP2K4 | 1.75248339 |
| 20 | PTK6 | 1.65911812 |
| 21 | NTRK3 | 1.62363101 |
| 22 | EPHB1 | 1.52731375 |
| 23 | MAPK11 | 1.44851878 |
| 24 | JAK1 | 1.28873630 |
| 25 | TGFBR2 | 1.24290908 |
| 26 | JAK2 | 1.20621463 |
| 27 | FER | 1.20290640 |
| 28 | PIK3CG | 1.19672483 |
| 29 | MAP3K7 | 1.17610300 |
| 30 | NTRK1 | 1.17084378 |
| 31 | LATS1 | 1.16280364 |
| 32 | NLK | 1.15600240 |
| 33 | PRKAA2 | 1.14627073 |
| 34 | NEK9 | 1.11646260 |
| 35 | FLT3 | 1.11566559 |
| 36 | PIK3CA | 1.11094445 |
| 37 | GRK6 | 1.09927599 |
| 38 | FGFR2 | 1.08657955 |
| 39 | MAP2K3 | 1.06668140 |
| 40 | TBK1 | 1.06122698 |
| 41 | EPHA3 | 1.02596645 |
| 42 | BMX | 1.02572654 |
| 43 | PRPF4B | 0.99219698 |
| 44 | ABL2 | 0.98524202 |
| 45 | BLK | 0.97586246 |
| 46 | SGK223 | 0.97298129 |
| 47 | SGK494 | 0.97298129 |
| 48 | CSK | 0.95242680 |
| 49 | EEF2K | 0.93690427 |
| 50 | MARK2 | 0.91906417 |
| 51 | KDR | 0.91331625 |
| 52 | MAP3K2 | 0.90662078 |
| 53 | FGFR3 | 0.88502925 |
| 54 | FRK | 0.87233026 |
| 55 | PDGFRB | 0.85558958 |
| 56 | ERBB2 | 0.84212767 |
| 57 | MELK | 0.83354223 |
| 58 | CDC42BPA | 0.81689468 |
| 59 | MAPK12 | 0.81113568 |
| 60 | MAP3K11 | 0.79933726 |
| 61 | TIE1 | 0.74380931 |
| 62 | MYLK | 0.72976188 |
| 63 | SMG1 | 0.70101604 |
| 64 | MAP3K13 | 0.68548645 |
| 65 | MAP3K10 | 0.68330321 |
| 66 | CDK12 | 0.68181114 |
| 67 | MAPK4 | 0.68029907 |
| 68 | MAP4K1 | 0.68024432 |
| 69 | PRKCH | 0.66092966 |
| 70 | SGK3 | 0.65479589 |
| 71 | SGK1 | 0.65079649 |
| 72 | PRKCZ | 0.64941182 |
| 73 | PRKACG | 0.64372838 |
| 74 | MAP3K6 | 0.64254324 |
| 75 | MAP3K14 | 0.63858405 |
| 76 | PDPK1 | 0.63798854 |
| 77 | MAP3K3 | 0.63564934 |
| 78 | IGF1R | 0.63119633 |
| 79 | MAP3K5 | 0.63007185 |
| 80 | NEK6 | 0.62522234 |
| 81 | CDK6 | 0.61888493 |
| 82 | GSK3A | 0.61252660 |
| 83 | HIPK2 | 0.60221403 |
| 84 | EPHB2 | 0.59792965 |
| 85 | LMTK2 | 0.58674673 |
| 86 | PDK2 | 0.58432501 |
| 87 | KIT | 0.58078971 |
| 88 | CSF1R | 0.56043291 |
| 89 | PINK1 | 0.55786193 |
| 90 | IRAK3 | 0.55378976 |
| 91 | TNK2 | 0.54303398 |
| 92 | PTK2 | 0.54257468 |
| 93 | RET | 0.53449340 |
| 94 | PRKAA1 | 0.52940504 |
| 95 | ICK | 0.51645025 |
| 96 | MAPK3 | 0.51600131 |
| 97 | MAPKAPK3 | 0.49778581 |
| 98 | IKBKE | 0.49419707 |
| 99 | CAMK2G | 0.48781208 |
| 100 | TYRO3 | 0.47535843 |
| 101 | PDGFRA | 0.47368733 |
| 102 | MAPK15 | 0.45531204 |
| 103 | PKN1 | 0.45500509 |
| 104 | PRKD1 | 0.45170567 |
| 105 | EGFR | 0.43833650 |
| 106 | DYRK1B | 0.42703642 |
| 107 | SRC | 0.42663719 |
| 108 | STK38 | 0.41803644 |
| 109 | FGFR1 | 0.41667070 |
| 110 | CAMKK1 | 0.41505752 |
| 111 | MAP2K6 | 0.40544004 |
| 112 | TTN | 0.40050828 |
| 113 | MAP3K1 | 0.39037722 |
| 114 | AKT2 | 0.38407137 |
| 115 | RPS6KA2 | 0.38365295 |
| 116 | MAPK7 | 0.38092985 |
| 117 | CAMK4 | 0.37696759 |
| 118 | MTOR | 0.36887295 |
| 119 | MAP2K1 | 0.36567560 |
| 120 | ZAP70 | 0.36325899 |
| 121 | JAK3 | 0.36250736 |
| 122 | PRKG1 | 0.35892285 |
| 123 | PDK1 | 0.35004799 |
| 124 | TRPM7 | 0.34593006 |
| 125 | RPS6KA3 | 0.33511747 |
| 126 | CDK4 | 0.30517712 |
| 127 | DAPK1 | 0.29762078 |
| 128 | SGK2 | 0.27954291 |
| 129 | PDK4 | 0.27656421 |
| 130 | PDK3 | 0.27656421 |
| 131 | IRAK1 | 0.27392295 |
| 132 | PRKCQ | 0.27232087 |
| 133 | HCK | 0.26912199 |
| 134 | DAPK3 | 0.24864625 |
| 135 | LRRK2 | 0.21471665 |
| 136 | EPHA2 | 0.21186413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38113552 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88735886 |
| 3 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.30143602 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.11762559 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11521043 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99317924 |
| 7 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69221727 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60078117 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55910217 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52317811 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49856036 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36983658 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32765220 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15309070 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.13329067 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11679567 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.03164713 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96865295 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96313069 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92530495 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91999754 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88080649 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74890536 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70192113 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69202805 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67623261 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62187206 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61532078 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.53612000 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52565680 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49627206 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.47948011 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46320553 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40501321 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39163501 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34189024 |
| 37 | ABC transporters_Homo sapiens_hsa02010 | 1.31261075 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30683070 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26421734 |
| 40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25727623 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20553012 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17703688 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.12759828 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09600733 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09439993 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07173967 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05783175 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95499305 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94648810 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93281235 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92013341 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89807486 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88723406 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86708449 |
| 55 | Lysine degradation_Homo sapiens_hsa00310 | 0.86372754 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81599674 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81287547 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80560701 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79932305 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78936497 |
| 61 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73307749 |
| 62 | Prion diseases_Homo sapiens_hsa05020 | 0.69111469 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64979732 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54474609 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53532904 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48951603 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.48567975 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44970571 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44474416 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44236604 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.41879845 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39311745 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.39286639 |
| 74 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37839739 |
| 75 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33657461 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.27707057 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25234728 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22759732 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.20749896 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19958294 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.19903344 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17572021 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.15515625 |
| 84 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14871412 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14177757 |
| 86 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09043379 |
| 87 | * Pertussis_Homo sapiens_hsa05133 | 0.04977284 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.04906103 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.04437607 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.03639942 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03325927 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00618890 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.00440446 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1752826 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1725054 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1718329 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1639596 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1630056 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1609167 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | -0.0971630 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0956853 |
| 102 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0923433 |
| 103 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0833831 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0684118 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0637645 |
| 106 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0548073 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | -0.0531653 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0507276 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0435990 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0357202 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0311310 |
| 112 | Malaria_Homo sapiens_hsa05144 | -0.0252298 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | -0.0107496 |

